TetraPhase Pharmaceuticals to Present at UBS 2010 Global Life Sciences Conference

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a portfolio of potent, novel and differentiated antibiotics designed to be effective against drug resistant bacteria, including multidrug-resistant (MDR) gram negative pathogens, today announced that the Company will present at the UBS Global Life Science Conference on Monday, September 20, at 9:30 am ET at the Grand Hyatt Hotel, New York City.

MORE ON THIS TOPIC